Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016

•The non-research payment data of 71 Japanese pharmaceutical companies in 2016 were examined.•The total value of the non-research payments was 1.8 billion USD.•Of these payments, identifiable details (e.g. the timing and name of events and promoted drugs) were disclosed in only 33.0 %•One company di...

Ausführliche Beschreibung